NCT04297072View on ClinicalTrials.gov

Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists

CompletedOBSERVATIONAL

Enrollment

25,000

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions

Non-Valvular Atrial Fibrillation

Interventions

DRUG

Rivaroxaban (Xarelto, BAY-597939)

Non-vitamin K antagonist oral anticoagulants (NOACs). The prescription of drug is at the discretion of physician following the routine clinical practice.

DRUG

VKAs

Oral anticoagulant. The prescription of drug is at the discretion of physician following the routine clinical practice.

Trial Locations (1)

Unknown

Many locations, Multiple Locations